-
October 04, 2012
Abbott Labs (ABT) recently announced that it has received approval for an additional indication of Humira ...
-
October 04, 2012
3M Company (MMM), a globally diversified technology company, has reorganized its business groups to better serve its ...
-
October 03, 2012
We are maintaining our Neutral recommendation on AmerisourceBergen Corporation (ABC), which carries a Zacks #3 Rank ...
-
October 01, 2012
Switzerland-based pharmaceutical company, Novartis AG (NVS) recently announced phase II data on its pipeline ...
-
September 27, 2012
The US approval process of Bristol-Myers Squibb Company/Pfizer Inc.'s (BMY/PFE) anti-clotting drug Eliquis ...
-
September 27, 2012
ETFs have earned the respect of countless investors as viable financial instruments well suited as core building ...
-
September 25, 2012
GlaxoSmithKline plc (GSK) performed disappointingly in the second quarter of 2012, missing the Zacks Consensus ...
-
September 25, 2012
Recently, Mallinckrodt, the Pharmaceuticals business of Covidien plc (COV), announced a definitive deal to acquire ...
-
September 25, 2012
Brand value can make old products into incredible winners.
-
September 24, 2012
Recently, Bristol-Myers Squibb Company (BMY) and partner, Pfizer Inc. (PFE) received some encouraging news with the ...
-
September 24, 2012
Covidien plc. (COV), a leading health care products company, recently announced a 16% hike in its quarterly dividend ...
-
September 21, 2012
The HealthCare unit of Bayer (BAYRY) announced recently that it has filed an application seeking approval to market ...
-
September 21, 2012
We have reaffirmed our Neutral recommendation on Myriad Genetics (MYGN) with a target price of $29.00. The company ...
-
September 20, 2012
Celgene Corporation (CELG) recently announced that Oncologic Drugs Advisory Committee (ODAC) of the US Food and Drug ...
-
September 20, 2012
Impax Laboratories, Inc. (IPXL) and Teva Pharmaceuticals USA, Inc., a wholly owned subsidiary of Teva Pharmaceutical ...
-
September 19, 2012
Covidien plc. (COV), a leading health care products company, recently introduced the Viance Crossing Catheter and ...
-
September 19, 2012
Encouraged by strong second quarter 2012 results, an upbeat guidance and a series of positive subsequent ...
-
September 18, 2012
We are moving back to a Neutral recommendation on Alkermes plc (ALKS) as we believe the stock is fairly valued at ...
-
September 17, 2012
Shire plc (SHPG) recently announced that the US Food and Drug Administration (FDA) has accepted the company's ...
-
September 17, 2012
Medivation, Inc. (MDVN) and Astellas Pharma Inc. recently launched their prostate cancer treatment, Xtandi ...
